bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Benign neoplasm: Short bones of lower limb
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_BONE_SHORT_LOWER
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
373 |
4. Check minimum number of eventsNone |
373 |
5. Include endpointsNone |
373 |
6. Filter based on genotype QC (FinnGen only) |
366 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossium brevium membri inferioris
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Short bones of lower limb
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3041 | 1554 | 1476 |
| Only index persons | 2761 | 1424 | 1337 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 30.95 | 34.28 | 27.27 |
| Only index persons | 29.13 | 32.51 | 25.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 366 | 221 | 145 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.07 |
| Median age at first event (years) | 35.23 | 32.35 | 39.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 373
- Matched controls
- 3730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.3
ICD-10 Finland
Benign neoplasm: Short bones of lower limb
+∞
255.7
215
*
21307
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium brevium extremitatis inferioris
+∞
103.0
94
*
2138A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Short bones of lower limb
+∞
70.0
65
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
242.2
61.1
61
*
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
15.0
41.4
38
28
9102
FHL
Trepanation or removal of the local bone process
70.9
39.1
44
7
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
16.2
38.7
34
23
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
20.9
19.8
29
15
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
31.9
18.6
24
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.8
16.6
55
161
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
6.1
11.9
21
36
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
102.5
9.5
10
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
11.9
9.1
16
14
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.3
168
1125
ZXA05
NOMESCO Finland
Left side
2.0
7.7
95
534
9103
FHL
Partial or complete bone removal
25.6
7.6
10
*
NHR99
NOMESCO Finland
Other operation for tumour of ankle or foot
81.7
7.4
8
*
9104
FHL
Autogenous bone graft
+∞
7.3
7
*
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
+∞
7.3
7
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.8
7.2
36
135
WX320
NOMESCO Finland
Spinalanesthesy
2.0
7.1
96
556
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.1
6.5
18
46
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.7
6.2
34
134
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
6.5
6.2
15
24
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
6.2
169
1208
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
183
1417
1.57
4.43
2.6
2.6
—
—
—
0
0
259
2274
1.45
2.79
4.1
4.0
9.49
10.76
mm/h
1.16
244
2097
7
16
4.44
2.48
1.4
3.6
68.43
98.25
nmol/l
—
7
16
13
51
2.60
2.47
1.3
1.2
—
—
—
0
0
13
51
2.60
2.47
1.3
1.2
—
—
—
0
0
11
40
2.80
2.29
1.6
1.1
—
—
—
0
0
6
14
4.34
2.16
1.7
3.3
255.67
760.79
u/ml
—
6
14
261
2351
1.37
2.03
4.5
4.0
14.50
14.58
pmol/l
0.23
248
2136
10
38
2.68
2.02
1.1
1.3
0.66
0.47
nmol/l
—
10
33
6
16
3.79
1.94
1.5
1.1
8.00
16.50
u/l
—
6
16
12
52
2.35
1.89
1.1
1.6
—
—
—
0
0
31
194
1.65
1.78
1.3
1.5
—
—
—
0
0
74
561
1.40
1.75
1.3
1.3
11.46
30.31
iu/ml
4.00
23
179
22
126
1.79
1.72
1.4
2.5
34.14
40.27
u/l
0.81
22
117
22
126
1.79
1.72
1.6
2.0
—
—
—
0
0
325
3082
1.42
1.49
14.5
13.1
19.56
22.32
mg/l
0.83
260
2402
100
815
1.31
1.48
4.1
3.8
0.00
0.01
estimate
0.69
32
289
87
697
1.32
1.45
2.1
2.3
—
—
—
0
0
60
455
1.38
1.42
3.6
3.6
0.81
0.82
mmol/l
0.28
54
430
113
946
1.28
1.36
3.2
2.6
94.75
60.94
u/l
0.37
103
876
0
37
0.00
1.35
0.0
3.0
—
33.14
—
0
37
300
2829
1.31
1.26
5.2
4.7
1.72
2.27
mu/l
0.71
289
2605
122
1045
1.25
1.20
3.5
3.0
—
—
—
0
0
49
372
1.37
1.17
2.6
2.2
23.69
23.76
%
0.01
42
324
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
170
1517
1.22
1.13
5.6
4.8
0.00
0.00
estimate
-0.00
37
296
292
2758
1.27
1.11
5.0
5.3
37.91
39.37
mmol/mol
2.26
273
2585
248
2308
1.22
1.05
7.7
7.5
78.03
77.76
u/l
0.03
239
2170
171
1536
1.21
1.04
4.2
3.5
0.00
0.00
estimate
-0.00
36
284
5
22
2.29
1.03
1.2
1.4
—
—
—
0
0
189
1715
1.21
1.03
4.7
5.0
6.27
6.55
mmol/l
1.58
180
1585
135
1187
1.22
1.02
4.5
3.6
—
—
—
0
0
137
1207
1.21
1.01
5.3
4.8
35.99
35.99
g/l
0.00
129
1130
26
182
1.46
0.99
1.0
1.0
—
—
—
0
0
142
1260
1.21
0.97
15.2
11.4
1.18
1.21
inr
0.18
51
381
66
540
1.27
0.95
1.2
1.3
1.49
11.03
u/ml
3.96
30
221
9
51
1.78
0.95
3.4
1.2
15.75
3.46
ug/l
—
9
44
11
62
1.80
0.95
1.4
1.2
—
—
—
0
0
9
52
1.75
0.93
1.2
1.3
—
—
—
0
0
9
52
1.75
0.93
1.2
1.1
—
—
—
0
0
308
2947
1.26
0.92
4.4
4.2
5.67
5.86
mmol/l
2.88
295
2707
6
28
2.16
0.92
1.0
1.0
—
—
—
0
0
355
3465
1.51
0.92
19.9
19.2
41.07
40.44
%
1.79
338
3273
314
3014
1.26
0.89
4.1
4.1
1.47
1.47
mmol/l
0.07
297
2806
315
3025
1.27
0.89
4.2
4.1
4.71
4.70
mmol/l
0.05
299
2829
355
3467
1.50
0.89
19.9
19.1
4.56
4.51
e12/l
1.07
348
3371
302
2890
1.24
0.86
12.2
11.8
85.34
85.64
ml/min/173m2
0.09
259
2357
89
765
1.21
0.84
2.5
2.8
343.18
6960.87
umol/l
3.08
80
672
12
73
1.67
0.82
1.4
1.3
—
—
—
0
0
60
496
1.25
0.81
3.2
2.9
0.75
0.75
ug/l
0.02
43
320
24
173
1.41
0.81
2.4
2.7
25.80
46.91
u/ml
0.63
24
167
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
30
226
1.36
0.79
4.1
2.6
61.25
70.46
ml/min/173m2
0.78
16
95
5
99
0.50
0.78
1.0
2.5
—
—
—
0
0
166
1516
1.17
0.78
4.2
3.5
0.00
0.00
estimate
0.50
35
307
354
3463
1.44
0.78
20.0
19.1
257.48
253.17
e9/l
0.58
349
3376
158
1438
1.17
0.78
4.9
5.7
56.55
57.04
%
0.22
153
1363
6
34
1.78
0.76
1.2
14.7
10.08
6.50
mmol/l
—
6
29
62
519
1.23
0.75
4.3
3.6
1204.49
183.46
ng/l
0.87
43
377
13
84
1.57
0.73
1.5
1.7
3.86
6.57
iu/l
—
5
27
7
40
1.76
0.71
1.0
1.0
1.26
1.45
g/l
—
7
35
159
1458
1.16
0.70
5.1
5.9
29.17
28.34
%
0.46
153
1385
5
27
1.86
0.68
1.2
1.5
1.35
1.24
promille
—
5
22
79
685
1.19
0.68
1.9
1.6
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
78
678
1.19
0.66
4.4
4.1
20.37
21.02
%
0.16
39
317
26
198
1.34
0.66
1.4
1.5
—
—
—
0
0
36
288
1.28
0.65
2.9
2.0
320.50
377.26
nmol/l
1.70
36
267
36
288
1.28
0.65
3.8
3.2
—
—
—
0
0
87
765
1.18
0.65
1.2
1.3
0.50
1.56
u/ml
2.67
21
226
16
112
1.45
0.64
2.2
1.8
—
—
—
0
0
302
2914
1.19
0.64
3.8
3.7
1.28
1.28
mmol/l
0.04
283
2704
10
63
1.60
0.62
1.6
1.3
127.20
113.21
u/ml
—
5
14
72
823
0.84
0.61
1.6
1.6
1.54
1.40
mmol/l
0.23
59
706
0
20
0.00
0.60
0.0
1.2
—
1.11
—
0
6
108
973
1.15
0.59
3.5
3.0
2.35
2.35
mmol/l
0.20
96
865
15
106
1.43
0.58
1.7
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
6
35
1.73
0.58
1.0
1.2
—
—
—
0
0
6
35
1.73
0.58
1.0
1.2
—
—
—
0
0
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
6
39
1.55
0.53
1.2
1.5
—
—
—
0
0
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
31
253
1.25
0.50
1.1
1.2
224.68
124.89
iu/ml
—
9
108
36
299
1.23
0.50
5.8
10.1
1.15
1.07
mmol/l
0.05
25
249
316
3078
1.17
0.50
4.5
4.5
2.79
2.81
mmol/l
0.12
300
2858
12
85
1.43
0.47
1.7
1.8
—
—
—
0
0
11
153
0.71
0.46
1.9
1.7
—
—
—
0
0
7
49
1.44
0.46
3.9
3.2
21.00
33.42
u/ml
—
7
49
10
69
1.46
0.44
1.6
1.3
—
—
—
0
0
166
1563
1.11
0.44
6.6
6.2
11.41
10.91
umol/l
0.17
156
1484
76
683
1.14
0.44
4.5
3.7
1.02
1.02
kg/l
0.19
13
95
91
828
1.13
0.44
3.0
2.8
0.51
0.42
e6/l
0.13
68
618
133
1240
1.11
0.42
2.3
2.3
77.43
74.56
nmol/l
0.59
124
1114
10
139
0.71
0.42
1.6
2.0
1.79
2.98
mg/l
—
5
97
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
8
57
1.41
0.42
2.1
4.2
57.37
56.51
%
—
8
57
5
33
1.52
0.41
3.4
3.5
—
—
—
0
0
15
114
1.33
0.41
1.5
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
41.30
—
0
11
0
18
0.00
0.40
0.0
1.0
—
498.18
—
0
11
23
187
1.25
0.40
1.3
1.3
—
—
—
0
0
5
35
1.43
0.39
1.2
1.3
—
—
—
0
0
75
825
0.89
0.39
4.1
3.7
10.54
10.29
mg/mmol
0.01
44
513
0
19
0.00
0.39
0.0
3.1
—
—
—
0
0
184
1754
1.10
0.37
8.0
9.4
4.04
4.05
e9/l
0.01
165
1543
79
721
1.12
0.37
2.3
2.0
2.94
3.13
mg/l
0.16
72
616
11
81
1.37
0.36
2.3
1.3
—
—
—
0
0
6
41
1.47
0.36
2.0
2.0
13.10
13.36
%
—
6
41
11
82
1.35
0.34
1.5
1.1
—
—
—
0
0
50
447
1.14
0.33
1.8
1.9
—
—
—
0
0
10
74
1.36
0.32
1.1
1.2
—
—
—
0
0
53
476
1.13
0.32
2.4
2.2
—
—
—
0
0
10
76
1.32
0.28
1.0
1.5
—
—
—
0
0
222
2152
1.08
0.27
3.4
3.1
44.87
44.09
u/l
0.06
210
2029
35
311
1.14
0.26
1.7
1.8
—
—
—
0
0
19
162
1.18
0.23
3.1
3.3
0.39
1.45
mmol/l
0.72
12
112
35
315
1.12
0.22
1.6
1.9
—
—
—
0
0
73
684
1.08
0.22
1.6
1.7
0.82
1.08
mg/l
0.76
52
525
13
107
1.22
0.22
1.5
1.4
—
—
—
0
0
13
107
1.22
0.22
1.5
1.4
—
—
—
0
0
13
107
1.22
0.22
1.5
1.4
—
—
—
0
0
13
107
1.22
0.22
1.2
1.6
—
231.43
—
0
7
13
107
1.22
0.22
1.5
1.4
—
—
—
0
0
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
407.00
—
0
7
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
37
337
1.11
0.20
5.7
6.4
—
—
—
0
0
6
50
1.20
0.20
1.2
1.8
—
—
—
0
0
19
165
1.16
0.19
1.5
1.3
—
—
—
0
0
27
301
0.89
0.19
1.7
1.6
—
—
—
0
0
131
1261
1.06
0.19
6.2
6.4
1.21
1.21
mmol/l
0.03
118
1156
14
119
1.18
0.18
2.1
1.5
—
—
—
0
0
7
60
1.17
0.18
1.3
1.3
—
—
—
0
0
17
148
1.16
0.17
2.4
2.2
420.86
4183.11
u/l
—
7
53
12
101
1.19
0.17
1.2
1.2
—
—
—
0
0
12
101
1.19
0.17
1.2
1.2
—
—
—
0
0
8
68
1.18
0.16
1.3
1.4
—
—
—
0
0
8
71
1.13
0.16
1.8
1.2
—
—
—
0
0
8
72
1.11
0.16
1.4
1.5
—
—
—
0
0
6
77
0.78
0.15
1.5
1.2
357.33
442.37
mg/l
—
6
71
6
77
0.78
0.15
5.5
4.4
—
2.72
—
0
10
31
285
1.10
0.14
2.5
2.4
26.81
31.41
u/l
0.89
26
241
7
90
0.77
0.14
3.0
2.6
—
—
—
0
0
13
112
1.17
0.14
1.8
2.0
—
—
—
0
0
8
99
0.80
0.14
1.5
1.6
—
—
—
0
0
116
1123
1.05
0.13
1.9
1.9
98.84
94.57
pmol/l
0.38
59
570
47
498
0.94
0.13
1.6
1.7
1607.85
1194.80
nmol/l
1.37
33
381
9
109
0.82
0.13
2.2
2.1
0.28
3.95
ug/l
—
9
101
105
1083
0.96
0.12
3.4
3.5
47.37
36.63
ng/l
0.18
68
697
12
105
1.15
0.11
2.1
2.1
—
—
—
0
0
15
167
0.89
0.11
5.7
6.0
25.04
24.74
mmol/l
0.10
15
167
61
585
1.05
0.10
1.6
1.7
411.26
13481318.50
pmol/l
0.50
53
497
70
676
1.04
0.09
1.5
1.5
22.57
21.43
nmol/l
0.27
65
574
23
215
1.07
0.08
3.6
1.9
—
—
—
0
0
11
98
1.13
0.07
2.1
1.9
—
—
—
0
0
6
71
0.84
0.07
1.3
1.1
3.00
3.95
e6/l
—
6
56
6
71
0.84
0.07
1.7
1.2
3.00
1641.95
e6/l
—
6
59
8
74
1.08
0.07
1.3
1.7
—
—
—
0
0
219
2165
1.03
0.07
3.1
3.4
—
—
—
0
0
53
513
1.04
0.06
2.6
2.6
2.45
2.44
mmol/l
0.13
44
440
45
434
1.04
0.06
2.3
2.0
—
—
—
0
0
48
464
1.04
0.06
3.0
2.7
8.82
2.54
e6/l
1.08
24
246
12
131
0.91
0.05
1.4
1.4
—
—
—
0
0
20
209
0.95
0.03
6.0
2.9
65.23
67.51
g/l
0.53
20
192
29
281
1.03
0.02
3.3
1.9
—
—
—
0
0
12
127
0.94
0.01
1.6
1.4
—
—
—
0
0
140
1391
1.01
0.01
7.8
7.0
1.22
1.21
mmol/l
0.21
123
1176
35
344
1.02
0.00
8.1
7.2
105.14
104.17
mmol/l
0.70
35
344
57
564
1.01
0.00
1.8
1.5
—
—
—
0
0
75
744
1.01
0.00
2.8
3.1
1429.14
951.29
ng/l
0.45
65
615
29
288
1.01
0.00
3.7
4.2
7.08
45.55
ug/l
0.77
21
237
50
498
1.00
0.00
2.8
2.5
1.67
0.93
e6/l
0.55
26
276
14
137
1.02
0.00
3.7
2.6
0.86
0.65
%
0.96
14
137
34
345
0.98
0.00
4.0
4.1
30.33
31.42
%
0.27
27
233
12
116
1.04
0.00
1.2
1.3
—
—
—
0
0
5
55
0.91
-0.00
1.8
1.5
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.8
—
—
—
0
0
5
54
0.92
-0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
-0.00
1.3
1.2
3.22
3.66
mmol/l
—
6
63
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
130.60
—
0
5
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BONE_SHORT_LOWER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BONE_SHORT_LOWER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_SHORT_LOWER – Benign neoplasm: Short bones of lower limb
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data